Long-term outcomes of a rapid deployment aortic valve: data up to 5 years†
Günther Laufer(Medical University of Vienna), Thorsten Wahlers(Centrum für Integrierte Onkologie), David Holzhey, Thomas Walther(Goethe University Frankfurt), Martin Andreas(Medical University of Vienna), Christoph Schmitz(American Institute of Biological Sciences), René Schramm(LMU Klinikum), Christophe Giot(Edwards Lifesciences (Switzerland)), Axel Haverich(Medizinische Hochschule Hannover), Friedrich W. Mohr(Leipzig Heart Institute), Parwis B. Rahmanian(University of Cologne), Matthias Roth(Kerckhoff Klinik), Malakh Shrestha(Mayo Clinic in Arizona)
Cited by 72
Related Papers
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k
Percutaneous Aortic Valve Replacement for Severe Aortic Stenosis in High-Risk Patients Using the Second- and Current Third-Generation Self-Expanding CoreValve Prosthesis
|Journal of the American College of Cardiology|2007|947
Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data
|The Lancet|2018|733
Chronic Kidney Disease and Coronary Artery Disease
|Journal of the American College of Cardiology|2019|716